A novel biosafety level 2 compliant tuberculosis infection model using a ΔleuDΔpanCD double auxotroph of Mycobacterium tuberculosis H37Rv and Galleria mellonella

References

• World Health Organization. Global Tuberculosis Report 2019. Geneva: WHO Press; 2019.
   Google Scholar
• Reid MJA, Arinaminpathy N, Bloom A, et al. Building a tuberculosis-free world: the Lancet Commission on tuberculosis. Lancet. 2019;393:1331–1384.
   PubMed Web of Science ®Google Scholar
• TB Alliance. Pretomanid and BPaL [Internet]. 2019. https://www.tballiance.org/access/pretomanid-and-bpal-regimen[Accessed 10 December 2019]
   Google Scholar
• Esposito S, Bianchini S, Blasi F. Bedaquiline and delamanid in tuberculosis. Expert Opin Pharmacother. 2015;16:2319–2330.
   PubMed Web of Science ®Google Scholar
• Dockrell HM, Smith SG. What have we learnt about BCG vaccination in the last 20 years? Front Immunol. 2017;8:1134.
   PubMed Web of Science ®Google Scholar
• Zhan L, Tang J, Sun M, et al. Animal models for tuberculosis in translational and precision medicine. Front Microbiol. 2017;8:717.
   PubMed Web of Science ®Google Scholar
• Williams A, Orme IM. Animal models of tuberculosis: an overview. Microbiol Spectr. 2016;4:TBTB2-004–2015.
   PubMed Web of Science ®Google Scholar
• Fonseca KL, Rodrigues PNS, Olsson IAS, et al. Experimental study of tuberculosis: from animal models to complex cell systems and organoids. PLoS Pathog. 2017;13:e1006421.
   PubMed Web of Science ®Google Scholar
• Orme IM. The mouse as a useful model of tuberculosis. Tuberculosis. 2003;83:112–115.
   PubMed Web of Science ®Google Scholar
• Tsai CJ-Y, Loh JMS, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7:214–229.
   PubMed Web of Science ®Google Scholar
• Pereira TC, Barros PPD, de Oliveira Fugisaki LR, et al. Recent advances in the use of Galleria mellonella model to study immune responses against human pathogens. J Fungi. 2018;4:E128.
   Web of Science ®Google Scholar
• Cutuli MA, Petronio Petronio G, Vergalito F, et al. Galleria mellonella as a consolidated in vivo model hosts: new developments in antibacterial strategies and novel drug testing. Virulence. 2019;10:527–541.
   PubMed Web of Science ®Google Scholar
• Asai M, Li Y, Singh Khara J, et al. Galleria mellonella: an infection model for screening compounds against the Mycobacterium tuberculosis complex. Front Microbiol. 2019;10:2630.
   PubMedGoogle Scholar
• Asai M, Li Y, Singh Khara J, et al. Use of the invertebrate Galleria mellonella as an infection model to study the Mycobacterium tuberculosis complex. J Vis Exp. 2019;(148):e59703.
   Web of Science ®Google Scholar
• Li Y, Spiropoulos J, Cooley W, et al. Galleria mellonella - a novel infection model for the Mycobacterium tuberculosis complex. Virulence. 2018;9:1126–1137.
   PubMed Web of Science ®Google Scholar
• Mouton JM, Heunis T, Dippenaar A, et al. Comprehensive characterization of the attenuated double auxotroph Mycobacterium tuberculosis ΔleuDΔpanCD as an alternative to H37Rv. Front Microbiol. 2019;10:1922.
   PubMed Web of Science ®Google Scholar
• Andreu N, Fletcher T, Krishnan N, et al. Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence. J Antimicrob Chemother. 2012;67:404–414.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for treatment of tuberculosis. 4th ed. Geneva: WHO Press; 2010.
   Google Scholar
• Ryan GJ, Shapiro HM, Lenaerts AJ. Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approach. Tuberculosis. 2014;94:511–518.
   PubMed Web of Science ®Google Scholar
• Sampson SL, Dascher CC, Sambandamurthy VK, et al. Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect Immun. 2004;72:3031–3037.
   PubMed Web of Science ®Google Scholar
• Hondalus MK, Bardarov S, Russell R, et al. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun. 2000;68:2888–2898.
   PubMed Web of Science ®Google Scholar
• Killiny N. Generous hosts: why the larvae of greater wax moth, Galleria mellonella is a perfect infectious host model? Virulence. 2018;9:860–865.
   PubMed Web of Science ®Google Scholar
• Finke MD. Complete nutrient content of four species of commercially available feeder insects fed enhanced diets during growth. Zoo Biol. 2015;34:554–564.
   PubMed Web of Science ®Google Scholar
• Wojda I. Immunity of the greater wax moth Galleria mellonella. Insect Sci. 2017;24:342–357.
   PubMed Web of Science ®Google Scholar
• Entwistle FM, Coote PJ. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis mycobacteria infections and antibiotic treatments. J Med Microbiol. 2018;67:585–597.
   PubMed Web of Science ®Google Scholar
• Sheehan G, Dixon A, Kavanagh K. Utilization of Galleria mellonella larvae to characterize the development of Staphylococcus aureus infection. Microbiology. 2019;165:863–875.
   PubMed Web of Science ®Google Scholar
• Harding CR, Schroeder GN, Reynolds S, et al. Legionella pneumophila pathogenesis in the Galleria mellonella infection model. Infect Immun. 2012;80:2780–2790.
   PubMed Web of Science ®Google Scholar
• Driver E, Ryan G, Hoff D, et al. Evaluation of mouse model forming necrotic granulomas using C3HeB/FeJ mice, for the testing of Mycobacterium tuberculosis drugs. Antimicrob Agents Chemother. 2012;56:3181–3195.
   PubMed Web of Science ®Google Scholar
• Nikonenko BV, Samala R, Einck L, et al. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2004;48:4550–4555.
   PubMed Web of Science ®Google Scholar
• Thomas RJ, Hamblin KA, Armstrong SJ, et al. Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. Int J Antimicrob Agents. 2013;41:330–336.
   PubMed Web of Science ®Google Scholar
• Gopal P, Nartey W, Ragunathan P, et al. Pyrazinoic acid inhibits mycobacterial coenzyme A biosynthesis by binding to aspartate decarboxylase PanD. ACS Infect Dis. 2017;3:807–819.
   PubMed Web of Science ®Google Scholar
• Andreu N, Zelmer A, Fletcher T, et al. Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One. 2010;5:e10777.
   PubMed Web of Science ®Google Scholar
• Myllymäki H, Bäuerlein CA, Rämet M. The zebrafish breathes new life into the study of tuberculosis. Front Immunol. 2016;7:196.
   PubMed Web of Science ®Google Scholar
• Myllymäki H, Niskanen M, Oksanen KE, et al. Animal models in tuberculosis research – where is the beef? Expert Opin Drug Discov. 2015;10:871–883.
   PubMed Web of Science ®Google Scholar
• Avdesh A, Chen M, Martin-Iverson MT, et al. Regular care and maintenance of a Zebrafish (Danio rerio) laboratory: an introduction. J Vis Exp. 2012;(69):e4196.
   PubMed Web of Science ®Google Scholar
• Flentie K, Garner AL, Stallings CL. Mycobacterium tuberculosis transcription machinery: ready to respond to host attacks. J Bacteriol. 2016;18:1360–1373.
   Google Scholar
• Vogel H, Altincicek B, Glöckner G, et al. A comprehensive transcriptome and immune-gene repertoire of the lepidopteran model host Galleria mellonella. BMC Genomics. 2011;12:308.
   PubMed Web of Science ®Google Scholar
• Lange A, Beier S, Huson DH, et al. Genome sequence of Galleria mellonella (greater wax moth). Genome Announc. 2018;6:e01220–17.
   PubMedGoogle Scholar
• Xu H, O’Brochta DA. Advanced technologies for genetically manipulating the silkworm Bombyx mori, a model lepidopteran insect. Proc R Soc B Biol Sci. 2015;282:20150487.
   PubMed Web of Science ®Google Scholar